Anti-angiogenic effect of resveratrol or curcumin in Ehrlich ascites carcinoma-bearing mice

European Journal of Pharmacology

Volumn 652, Issue 1-3, 2011, Pages 7-14

  El Azab, Mona ^a   Hishe, Hailemichael ^a,b   Moustafa, Yasser ^a   El Awady, El Sayed ^a  

^a Suez Canal University   (Egypt)

^b MEKELLE UNIVERSITY   (Ethiopia)

Author keywords

Angiogenesis; Carboplatin; Curcumin; Microvessel density; Resveratrol; VEGF

Indexed keywords

CARBOPLATIN; CURCUMIN; RESVERATROL; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG MECHANISM; EHRLICH ASCITES TUMOR; FEMALE; MICROVASCULATURE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TISSUE LEVEL; TUMOR VOLUME;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; CURCUMIN; MICE; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; STILBENES; TIME FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 78650859920     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.11.008     Document Type: Article

References (60)

1. D. Abraham, S. Abri, M. Hofmann, W. Höltl, and S. Aharinejad Low dose carboplatin combined with angiostatic agents prevents metastasis in human testicular germ cell tumor xenografts J. Urol. 170 2003 1388 1393
2. H. Ammon, and M. Wahl Pharmacology of Curcuma longa Planta Med. 57 1991 1 7
3. J. Arbiser, N. Klauber, R. Rohan, R. van Leeuwen, M. Huang, C. Fisher, E. Flynn, and H. Byers Curcumin is an in vivo inhibitor of angiogenesis Mol. Med. 4 1998 376 383
4. Baur J., and Sinclair D. Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discov. 5 2006 493 506
5. M. Belakavadi, and B. Salimath Mechanism of inhibition of ascites tumor growth in mice by curcumin is mediated by NF-kB and caspase activated DNase Mol. Cell. Biochem. 273 2005 57 67
6. T. Bhat, and R. Singh Tumor angiogenesis - a potential target in cancer chemoprevention Food Chem. Toxicol. 46 2008 1334 1345
7. R. Binétruy-Tournaire, C. Demangel, B. Malavaud, R. Vassy, S. Rouyre, M. Kraemer, J. Plouët, C. Derbin, G. Perret, and J. Mazié Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis EMBO J. 19 2000 1525 1533
8. E. Brakenhielm, R. Cao, and Y. Cao Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes Fed. Am. Soc. Exp. Biol. J. 15 2001 1798 1800
9. Z. Cao, J. Fang, C. Xia, X. Shi, and B. Jiang Trans-3, 4, 50-trihydroxystibene inhibits hypoxia-inducible factor 1 alpha and vascular endothelial growth factor expression in human ovarian cancer cells Clin. Cancer Res. 10 2004 5253 5263 (Pubitemid 39099800)
10. J. Chen, J. Zhu, J. Hong, M. Chen, J. Lu, W. Chen, B. Shen, Z. Zhu, and N. Chen Effect of 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid in combination with carboplatin on gastric carcinoma growth in vivo World J. Gastroenterol. 13 2007 509 514
11. G. Di, H. Li, Z. Shen, and Z. Shao Analysis of antiproliferation of curcumin on human breast cancer cells and its mechanism Zhonghua Yi Xue Za Zhi 83 2003 1764 1768
12. T. Dorai, and B. Aggarwal Role of chemopreventive agents in cancer therapy Cancer Lett. 215 2004 129 140
13. T. Dorai, Y. Cao, B. Dorai, R. Buttyan, and A. Katz Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo Prostate 47 2001 293 303
14. E. El-Awady, M. El-Azab, Y. Moustafa, and A. Abd-El-Hamid Role of vascular endothelial growth factor in Ehrlich ascites carcinoma: modulatory effects of thalidomide, rofecoxib and captopril Bull. Fac. Pharm. Cairo. Univ. 44 2006 1 16
15. M. El-Azab, H. Hishe, Y. Moustafa, and E. El-Awady Effect of resveratrol and curcumin on tumor volume and survival in Ehrlich ascites carcinoma-bearing mice Bull. Fac. Pharm. Cairo. Univ. 47 2009 207 223
16. M. Emoto, M. Ishiguro, H. Iwasaki, M. Kikuchi, and T. Kawarabayashi Effect of angiogenesis inhibitor TNP-470 on the growth, blood flow, and microvessel density in xenografts of human uterine carcinosarcoma in nude mice Gynecol. Oncol. 89 2003 88 94
17. N. Ferrara Role of vascular endothelial growth factor in regulation of angiogenesis B.A. Teicher, Antiangiogenic Agents in Cancer Therapy 1999 Totowa Humana Press 3 21
18. N. Ferrara VEGF: an update on biological and therapeutic aspects Curr. Opin. Biotechnol. 11 2000 617 624
19. N. Ferrara VEGF and the quest for tumour angiogenesis factors Nat. Rev. Cancer 2 2002 795 803
20. J. Folkman Anti-angiogenesis: new concept for therapy of solid tumors Ann. Surg. 175 1972 409 416
21. J. Folkman, E. Merler, C. Abernathy, and G. Williams Isolation of a tumor factor responsible for angiogenesis J. Exp. Med. 133 1971 275 288
22. S. Garvin, K. Ollinger, and C. Dabrosin Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo Cancer Lett. 231 2006 113 122
23. T. Graeber, C. Osmanian, T. Jacks, D. Housman, C. Koch, S. Lowe, and A. Giaccia Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 1996 88 91
24. J. Grunstein, W. Roberts, O. Mathieu-Costello, D. Hanahan, and R. Johnson Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function Cancer Res. 59 1999 1592 1598
25. A. Guidi, S. Schnitt, L. Fischer, K. Tognazzi, J. Harris, H. Dvorak, and L. Brown Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast Cancer 80 1997 1945 1953 (Pubitemid 27479789)
26. A. Gururaj, M. Belakavadi, D. Venkatesh, D. Marmé, and B. Salimath Molecular mechanisms of anti-angiogenic effect of curcumin Biochem. Biophys. Res. Commun. 297 2002 934 942
27. L. Hlatky, P. Hahnfeldt, and J. Folkman Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us J. Natl Cancer Inst. 94 2002 883 893
28. Y. Kimura, and H. Okuda Resveratrol isolated from polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice J. Nutr. 131 2001 1844 1849
29. J. Kundu, and Y. Surh Molecular basis of chemoprevention by resveratrol: NF-kB and AP-1 as potential targets Mutat. Res. 555 2004 65 80
30. R. Kuttan, P. Bhanumathy, K. Nirmala, and M. George Potential anticancer activity of turmeric (Curcuma longa) Cancer Lett. 129 1985 197 202
31. H. Lazarus, W. Tegeler, H. Mazzone, J. Leroy, B. Boone, and G. Foley Determination of sensitivity of individual biopsy specimens to potential inhibitory agents: evaluation of some explant culture methods as assay systems Cancer Chemother. Rep. 50 1966 543 555
32. X. Li, G. Feng, C. Zheng, C. Zhuo, and X. Liu Influence of transarterial chemoembolization on angiogenesis and expression of vascular endothelial growth factor and basic fibroblast growth factor in rat with Walker-256 transplanted hepatoma: an experimental study World J. Gastroenterol. 9 2003 2445 2449
33. J. Lokich, and N. Anderson Carboplatin versus cisplatin in solid tumors: an analysis of the literature Anna. Onco. 9 1998 13 21
34. R. Mohan, J. Sivak, P. Ashton, L. Russo, B. Pham, N. Kasahara, M. Raizman, and M. Fini Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B J. Biol. Chem. 275 2000 10405 10412
35. S. Mousa, S. Mousa, and S. Mousa Effect of resveratrol on angiogenesis and platelet/fibrin accelerated tumor growth in the chick chorioallantoic membrane model Nutr. Cancer 52 2005 59 65
36. L. Nakopoulou, K. Stefanaki, E. Panayotopoulou, I. Giannopoulou, P. Athanassiadou, H. Gakiopoulou-Givalou, and A. Louvrou Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation Hum. Pathol. 9 2002 863 887
37. P. Negi, G. Jayaprakasha, L. Jagan Mohan Rao, and K. Sakariah Antibacterial activity of turmeric oil: a byproduct from curcumin manufacture J. Agric. Food Chem. 47 1999 4297 4300
38. G. Neufeld, T. Cohen, S. Gengrinovitch, and Z. Poltorak Vascular endothelial growth factor (VEGF) and its receptors FASEB J. 13 1999 9 22
39. A. Obermair, P. Kohlberger, D. Bancher-Todesca, C. Tempfer, G. Sliutz, S. Leodolter, A. Reinthaller, C. Kainz, G. Breitenecker, and G. Gitsch Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer Gynecol. Oncol. 63 1996 204 209
40. K. Pajusola, O. Aprelikova, J. Korhonen, A. Kaipainen, L. Pertovaara, R. Alitalo, and K. Alitalo FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines Cancer Res. 52 1992 5738 5743
41. I. Sheriffs, D. Rampling, and V. Smith Paraffin wax embedded muscle is suitable for the diagnosis of muscular dystrophy J. Clin. Pathol. 54 2001 517 520
42. M. Shibuya, and L. Claesson-Welsh Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis Exp. Cell Res. 312 2006 549 560
43. G. Sidhu, A. Singh, D. Thaloor, K. Banaudha, G. Patnaik, R. Srimal, and R. Maheshwari Enhancement of wound healing by curcumin in animals Wound Repair Regen. 6 1998 167 177
44. A. Singh, G. Sidhu, T. Deepa, and R. Maheshwari Curcumin inhibits the proliferation and cell cycle progression of human umbilical vein endothelial cell Cancer Lett. 107 1996 109 115
45. Z. Tang, X. Liu, and P. Zou Resveratrol inhibits the secretion of vascular endothelial growth factor and subsequent proliferation in human leukemia U937 cells J. Huazhong Univ. Sci. Technolog. Med. Sci. 27 2007 508 512
46. B. Terman, M. Carrion, E. Kovacs, B. Rasmussen, R. Eddy, and T. Shows Identification of a new endothelial cell growth factor receptor tyrosine kinase Oncogene 6 1991 1677 1683
47. S. Toda, T. Miyase, H. Arichi, H. Tanizawa, and Y. Takino Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L Chem. Pharm. Bull. 33 1985 1725 1728
48. M. Toi, K. Inada, H. Suzuki, and T. Tominaga Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression Breast Cancer Res. Treat. 36 1995 193 204
49. F. Tosetti, N. Ferrari, S. Deflora, and A. Albini 'Angioprevention': angiogenesis is a common key target for cancer chemopreventive agents FASEB J. 16 2002 2 14
50. S. Traweek, P. Kandalaft, P. Mehta, and H. Battifora The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia Am. J. Clin. Pathol. 96 1991 25 31
51. S. Tseng, S. Lin, and J. Chen Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats Clin. Cancer Res. 10 2004 2190 2202
52. M. van de Rijn, C. Lombard, and R. Rouse Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung Am. J. Surg. Pathol. 18 1994 814 820
53. P. van Ginkel, D. Sareen, L. Subramanian, Q. Walker, S. Darjatmoko, and M. Lindstrom Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria Clin. Cancer Res. 13 2007 5162 5169
54. T. Veikkola, M. Karkkainen, L. Claesson-Welsh, and K. Alitalo Regulation of angiogenesis via vascular endothelial growth factor receptors Cancer Res. 60 2000 203 212 (Pubitemid 30070735)
55. W. Wang, G. Xu, W. Jia, Z. Wang, J. Li, J. Ma, Y. Ge, S. Xie, and J. Yu Expression and correlation of hypoxia-inducible factor-1 alpha, vascular endothelial growth factor and microvessel density in experimental rat hepatocarcinogenesis J. Int. Med. Res. 37 2009 417 425
56. N. Weidner Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors Breast Cancer Res. Treat. 36 1995 169 180
57. N. Weidner Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues to grow J. Pathol. 184 1998 119 122
58. H. Yoshiji, S. Harris, and U. Thorgeirsson Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells Cancer Res. 57 1997 3924 3928
59. Q. Zhang, X. Tang, Q. Lu, Z. Zhang, J. Brown, and A. Le Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1α and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells Mol. Cancer Ther. 4 2005 1465 1474
60. Z. Zhu, and L. Witte Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor Invest. New Drugs 17 1999 195 212